BCRX

insider transactions

BIOCRYST PHARMACEUTICALS INC — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 90d

-73.7K

0 buy · 73.7K sell

Net value · 90d

-$696.5K

$0 in · $696.5K out

Sentiment · 90d

Net selling

0% buying · 100% selling

Open-market trades · 90d

0 buy · 73.7K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 11, 26

Jill C. Milne

Director

$0

33.5K sh

Own New
Grant·A
Jun 11, 26

Jill C. Milne

Director

$0

15.3K sh

Own +92%
Grant·A
Jun 11, 26

Steven K Galson

Director

$0

33.5K sh

Own New
Grant·A
Jun 11, 26

Steven K Galson

Director

$0

15.3K sh

Own +122%
Grant·A
Jun 11, 26

Alan G Levin

Director

$0

33.5K sh

Own New
Grant·A
Jun 11, 26

Alan G Levin

Director

$0

15.3K sh

Own +24%
Grant·A
Jun 11, 26

Steven Frank

Director

$0

33.5K sh

Own New
Grant·A
Jun 11, 26

Steven Frank

Director

$0

15.3K sh

Own +76%
Grant·A
Jun 11, 26

Machelle Sanders

Director

$0

33.5K sh

Own New
Grant·A
Jun 11, 26

Machelle Sanders

Director

$0

15.3K sh

Own +50%
Grant·A
Jun 11, 26

Vincent Milano

Director

$0

33.5K sh

Own New
Grant·A
Jun 11, 26

Vincent Milano

Director

$0

15.3K sh

Own +16%
Grant·A
Jun 11, 26

Jon P Stonehouse

Director

$0

33.5K sh

Own New
Grant·A
Jun 11, 26

Jon P Stonehouse

Director

$0

15.3K sh

Own +1%
Grant·A
Jun 11, 26

Amy E Mckee

Director

$0

33.5K sh

Own New
Grant·A
Jun 11, 26

Amy E Mckee

Director

$0

15.3K sh

Own +48%
Grant·A
Jun 11, 26

Theresa Heggie

Director

$0

33.5K sh

Own New
Grant·A
Jun 11, 26

Theresa Heggie

Director

$0

15.3K sh

Own +23%
Grant·A
May 29, 26

Jill C. Milne

Director

$11.2K

1.3K sh · $8.91

Own +8%
Grant·A
May 29, 26

Jon P Stonehouse

Director

$5.6K

631 sh · $8.91

Own +0%
Grant·A
May 29, 26

Amy E Mckee

Director

$5.6K

631 sh · $8.91

Own +2%
Grant·A
May 29, 26

Vincent Milano

Director

$10.0K

1.1K sh · $8.91

Own +1%
Grant·A
May 29, 26

Steven Frank

Director

$11.2K

1.3K sh · $8.91

Own +7%
Sell·S
May 18, 26

Amy E Mckee

Director

$100.3K

11.2K sh · $8.97

Own -26%
Exercise·M
May 13, 26

Alane P Barnes

Chief Legal Officer · 10b5-1

$0

62.5K sh

Own New
Sell·S
May 13, 26

Alane P Barnes

Chief Legal Officer · 10b5-1

$596.2K

62.5K sh · $9.54

Own -13%
Exercise·M
May 13, 26

Alane P Barnes

Chief Legal Officer · 10b5-1

$315.0K

62.5K sh · $5.04

Own +16%
Grant·A
Apr 6, 26

Sandeep Menon

Chief R&D Officer

$0

441.4K sh

Own New
Grant·A
Apr 6, 26

Sandeep Menon

Chief R&D Officer

$0

205.2K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 11, 2026	Jill C. Milne	Director	Grant A	33.5K	New	—	$0
Jun 11, 2026	Jill C. Milne	Director	Grant A	15.3K	+92%	—	$0
Jun 11, 2026	Steven K Galson	Director	Grant A	33.5K	New	—	$0
Jun 11, 2026	Steven K Galson	Director	Grant A	15.3K	+122%	—	$0
Jun 11, 2026	Alan G Levin	Director	Grant A	33.5K	New	—	$0
Jun 11, 2026	Alan G Levin	Director	Grant A	15.3K	+24%	—	$0
Jun 11, 2026	Steven Frank	Director	Grant A	33.5K	New	—	$0
Jun 11, 2026	Steven Frank	Director	Grant A	15.3K	+76%	—	$0
Jun 11, 2026	Machelle Sanders	Director	Grant A	33.5K	New	—	$0
Jun 11, 2026	Machelle Sanders	Director	Grant A	15.3K	+50%	—	$0
Jun 11, 2026	Vincent Milano	Director	Grant A	33.5K	New	—	$0
Jun 11, 2026	Vincent Milano	Director	Grant A	15.3K	+16%	—	$0
Jun 11, 2026	Jon P Stonehouse	Director	Grant A	33.5K	New	—	$0
Jun 11, 2026	Jon P Stonehouse	Director	Grant A	15.3K	+1%	—	$0
Jun 11, 2026	Amy E Mckee	Director	Grant A	33.5K	New	—	$0
Jun 11, 2026	Amy E Mckee	Director	Grant A	15.3K	+48%	—	$0
Jun 11, 2026	Theresa Heggie	Director	Grant A	33.5K	New	—	$0
Jun 11, 2026	Theresa Heggie	Director	Grant A	15.3K	+23%	—	$0
May 29, 2026	Jill C. Milne	Director	Grant A	1.3K	+8%	$8.91	$11.2K
May 29, 2026	Jon P Stonehouse	Director	Grant A	631	+0%	$8.91	$5.6K
May 29, 2026	Amy E Mckee	Director	Grant A	631	+2%	$8.91	$5.6K
May 29, 2026	Vincent Milano	Director	Grant A	1.1K	+1%	$8.91	$10.0K
May 29, 2026	Steven Frank	Director	Grant A	1.3K	+7%	$8.91	$11.2K
May 18, 2026	Amy E Mckee	Director	Sell S	11.2K	-26%	$8.97	$100.3K
May 13, 2026	Alane P Barnes 10b5-1	Chief Legal Officer	Exercise M	62.5K	New	—	$0
May 13, 2026	Alane P Barnes 10b5-1	Chief Legal Officer	Sell S	62.5K	-13%	$9.54	$596.2K
May 13, 2026	Alane P Barnes 10b5-1	Chief Legal Officer	Exercise M	62.5K	+16%	$5.04	$315.0K
Apr 6, 2026	Sandeep Menon	Chief R&D Officer	Grant A	441.4K	New	—	$0
Apr 6, 2026	Sandeep Menon	Chief R&D Officer	Grant A	205.2K	New	—	$0

About BCRX insider trading

This page tracks insider transactions for BIOCRYST PHARMACEUTICALS INC (BCRX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.